Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000080255-25-000208
Filing Date
2025-02-14
Accepted
2025-02-14 09:44:09
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 5628
  Complete submission text file 0000080255-25-000208.txt   7465
Mailing Address P.O. BOX 89000 BALTIMORE MD 21289
Business Address 100 EAST PRATT ST BALTIMORE MD 21202 (410)345-2000
PRICE T ROWE ASSOCIATES INC /MD/ (Filed by) CIK: 0000080255 (see all company filings)

EIN.: 520556948 | State of Incorp.: MD | Fiscal Year End: 1231
Type: SCHEDULE 13G
SIC: 6200 Security & Commodity Brokers, Dealers, Exchanges & Services
(CF Office: 09 Crypto Assets)

Mailing Address DORFSTRASSE 29 ZUG V8 6300
Business Address DORFSTRASSE 29 ZUG V8 6300 41 41 510 8022
MoonLake Immunotherapeutics (Subject) CIK: 0001821586 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-91803 | Film No.: 25624053
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)